|Videos|May 24, 2017

What Do I Need to Know About Lyme Transmission Time?

Patricia Smith, President of the Lyme Disease Association, Inc, explains what you need to know about the time it takes for Lyme to be transmitted from tick to host.

Patricia Smith, President of the Lyme Disease Association, Inc, explains what you need to know about the time it takes for Lyme to be transmitted from tick to host.

Interview Transcript (slightly modified for readability):

“Lyme transmission time is something that you have to be really concerned about. There is information out there that [transmission] takes 72 hours, 48 hours, or 24 hours. That information was based on the fact that, initially, it was felt that the Borrelia bacteria that causes Lyme disease was found in the midgut of the tick, and so, during the feeding process, [the bacteria] have to go from the midgut to the salivary glands in order to go into whatever [the tick] is biting. But, now, researchers have found that sometimes, this migration process has already started.

The tick [might have] had an incomplete feeding—perhaps it bit you and it didn’t like you!—and, so it falls off and decides it’s going to feed on somebody else. That tick will already have the bacteria in its salivary glands, and so it will be able to transmit [the bacteria] very quickly. There may [also] be other factors [place] the bacteria in the salivary glands at the start [of the feeding] and so that is very problematic.

The problem with transmission times is sometimes doctors will say, ‘Well, that tick was not on you long enough, and so you could not have Lyme disease’ and they do not even want to consider [Lyme] in a differential diagnosis. This is something that has to change. Doctors have to realize that this isn’t true. You have to look at your patient, [and] if they have a history of a tick bite, then you should be looking for different tick-borne diseases. Other kinds of co-infections, such as Powassan virus, are already known to be able to be transmitted in a very short period of time. They do not have the same issue as having to migrate.”


Related to this article

The Prospective Emergence of XDR Shigella Beyond High-Risk Groups
Los Angeles has been experiencing this challenging bacteria in recent years with the potential of it becoming carbapenem-resistant in the future. Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP), provides commentary about his team's work in this area and the role of genomic sequencing to uncover this troublesome pathogen.
Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.